Authors
Yan-Jiang Zhang, Yi-Ling Liao, Lu Gan, Long Jiang, Tao Yuan, Sheng Yin, Gui-Hua Tang
Published in
Journal of natural products. Jul 03, 2026. Epub Jul 03, 2026.
Abstract
A molecular networking-guided investigation of extracts from the growth medium of the endophytic fungus Trichoderma harzianum MLJ-4 resulted in the isolation of eight new polycyclic-fused cytochalasins (CYTs), triharziachalasins A-H (1-8), along with six known analogues (9-14). Their structures, including absolute configurations, were elucidated by comprehensive spectroscopic analysis, NMR calculations with DP4+ analysis, theoretical ECD simulations, and single-crystal X-ray diffraction. Compounds 1-3 feature a rare 5/6/5/8-fused tetracyclic system, while 4-8 possess a novel 5/6/6/7/5-fused pentacyclic scaffold. Compound 1 is the first cytochalasin analogue containing a cis-fused 5/8 ring within the 5/6/5/8 framework. All CYTs were evaluated for antiliver fibrosis activity in TGF-β1-stimulated LX-2 cells using high-content screening assays. The most promising compound, triharziachalasin H (8), dose-dependently suppressed the expression of key fibrotic markers, including fibronectin (FN), collagen I, and α-smooth muscle actin (α-SMA). Mechanism studies revealed that its antiliver fibrosis effect is mediated via inhibition of the NF-κB signaling pathway. This work expands the structural diversity of bioactive CYTs and reveals the antiliver fibrosis activity of this novel polycyclic-fused architecture, highlighting its potential as a lead compound for antiliver fibrosis drug development.
PMID:
42397140
Bibliographic data and abstract were imported from PubMed on 03 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0